Helen L. Fitzsimons

Safety and tolerability of gene therapy with an adeno-associated virus (AAV) borne GAD gene for Parkinson's disease: an open label, phase I trial

Michael G. Kaplitt, Andrew Feigin, Chengke Tang et al. · The Lancet · 2007 · 1.1K citations

Adeno-associated Virus, Medical Treatment, Borne Gad Gene +4

Glucagon-like peptide-1 receptor is involved in learning and neuroprotection

Matthew J. During, Lei Cao, David S. Zuzga et al. · Nature Medicine · 2003 · 831 citations

Glucagon-like Peptide-1 Receptor, G Protein-coupled Receptor, Neuropeptide Receptor +3

Subthalamic GAD Gene Therapy in a Parkinson's Disease Rat Model

Jia Luo, Michael G. Kaplitt, Helen L. Fitzsimons et al. · Science · 2002 · 324 citations

An Oral Vaccine Against NMDAR1 with Efficacy in Experimental Stroke and Epilepsy

Matthew J. During, C. Wymond Symes, P. Lawlor et al. · Science · 2000 · 219 citations

Quantitative comparison of expression with adeno-associated virus (AAV-2) brain-specific gene cassettes

Rui‐Hua Xu, C. G. Janson, Mihail Y. Mastakov et al. · Gene Therapy · 2001 · 175 citations

Adeno-associated Virus, Brain-specific Gene Cassettes, Virology +8